Nuclear factor (NF)-kappaB proteins: therapeutic targets.
about
Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targetsNMR Structure of Carcinoscorpius rotundicauda Thioredoxin-related Protein 16 and Its Role in Regulating Transcription Factor NF- B ActivityOlprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in micePDE 7 inhibitors: new potential drugs for the therapy of spinal cord injuryEffect of natural and semisynthetic pseudoguianolides on the stability of NF-κB:DNA complex studied by agarose gel electrophoresisPentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro EvidencesBCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.Effects of Hypericum Perforatum, in a rodent model of periodontitisEffects of plant-based Korean food extracts on lipopolysaccharide-stimulated production of inflammatory mediators in vitro.MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma.NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells.RelA repression of RelB activity induces selective gene activation downstream of TNF receptorsAn adeno-associated virus-based intracellular sensor of pathological nuclear factor-κB activation for disease-inducible gene transfer.Intra-Spinal Bone Marrow Mononuclear Cells Transplantation Inhibits the Expression of Nuclear Factor-κB in Acute Transection Spinal Cord Injury in Rats.Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularizationGlucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.NF-κB in Aging and DiseaseSelective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.Anti-chemokine autoantibody:chemokine immune complexes activate endothelial cells via IgG receptors.Anti-aging effects of guanosine in glial cells.Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies.Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.The role of the ubiquitin-editing enzyme A20 in diseases of the central nervous system and other pathological processes.Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic.Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicinDecreased Secondary Lesion Growth and Attenuated Immune Response after Traumatic Brain Injury in Tlr2/4-/- Mice.Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in miceSystemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathologyEffect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice.Patented inhibitors (2002 - 2005) of the transcription factor NF-kappaB.Neuroprotective Potential of Gentongping in Rat Model of Cervical Spondylotic Radiculopathy Targeting PPAR-γ Pathway.Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.Effects of NF-κB blocker curcumin on oogenesis and immunocompetent organ cells in immune ovarian injury in mice.Synthesis of Novel Oxazolo[4,5-b]pyridine-2-one based 1,2,3-triazoles as Glycogen Synthase Kinase-3β Inhibitors with Anti-inflammatory Potential.Elevated metabolic rate and skeletal muscle oxidative metabolism contribute to the reduced susceptibility of NF-κB p50 null mice to obesityDingchuan tang essential oil inhibits the production of inflammatory mediators via suppressing the IRAK/NF-κB, IRAK/AP-1, and TBK1/IRF3 pathways in lipopolysaccharide-stimulated RAW264.7 cells
P2860
Q27004250-9679001C-97D7-4790-85CC-C43FADCA5C3DQ27670644-C51B97FE-602C-4264-867B-1396C02F9F8DQ28475420-DD015C5F-C398-40F5-A3B3-3D9287508092Q28477025-9DEA1240-17E0-4E76-B930-4F8DE4FCD930Q28543064-EA47D6A4-0691-4DE3-BEC4-4DD1E34491D9Q28546967-041AE18E-D7BB-4EF9-83EE-819DED324C42Q30432099-3377887E-E1B4-4D11-96D8-1C25E8928E04Q33752118-02C31D6E-E7F4-4F0B-AF77-9B90B6EEE517Q33758939-53FC6DD2-FADD-46E9-BC14-C3A3477DA18FQ33872820-E0D181A0-7B2D-4690-9CC1-2ACEC4FE6DB0Q34013972-BC404C6F-AAE6-4292-A863-164E36969968Q34078586-172C0384-9C75-42BD-B384-7FE27F36906FQ34542364-012E6628-FFCD-41BF-BE37-3E4E76495FD9Q34749818-AE269737-F59F-4560-81AA-EA18D8DD2C54Q35587729-2DC97335-EF1A-47C1-8C23-826DD427DCC7Q35729623-B85188EE-D487-44BB-8F0D-A6CDBC5E274BQ35806773-7B903B17-E01F-4560-8A55-0D3317343D0DQ37143375-41786DF4-5741-4229-ABC8-1745302A7084Q37275471-93AD0F8D-B190-4801-8E48-240E18A54767Q37442075-B90B0FA8-AD09-4EE2-B09E-5E223C0E6FD3Q37493306-76521750-9C4F-4C33-A159-102A7BB4B3E0Q38272127-3FCD11F6-4B5E-4606-A265-9C7278B7E063Q38540498-8216011A-42F2-47C1-84F5-24613C018743Q39929542-65B3BC1A-4F82-48FB-8573-32AF10F3332CQ39958680-66F5CD86-4D28-4558-9561-ED90596F26DBQ41598774-968EB75E-BDBB-4889-9BA0-E17821988991Q41603437-DD86A347-14E4-4500-A861-B4EC9996C479Q41999142-CB9F1916-1CAD-414F-ACF9-D120ABB526D1Q43194454-C8E04F50-C046-418F-9DAB-B12E59AAA4B3Q45856870-73777C16-6B70-46D0-9025-B90E25E39E58Q47259552-8EB616BC-5A63-4EA2-BF90-9757392043D3Q47661011-8D677437-0814-458D-8484-7157AA920091Q48652512-EDD04573-8AD3-4F63-B533-34EEA1A1DEC7Q54219824-D76CA6D6-A247-4427-A763-6D58823851ABQ58699521-72667710-37B7-41C8-BEC7-3F66A3649A97Q58764997-1BC198CD-16B1-4966-B0E9-7123FBA2D2EC
P2860
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
@ast
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
@en
type
label
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
@ast
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
@en
prefLabel
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
@ast
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
@en
P2860
P356
P1476
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
@en
P2093
P2860
P304
P356
10.1136/ARD.2004.028266
P407
P478
63 Suppl 2
P577
2004-11-01T00:00:00Z